D

DROVANDI S.

Last name: DROVANDI S.

2020 (v1)

Publication

Metadata-only

Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy

Russo E. Drovandi S. Salvidio G.

Background and aims: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and a leading cause of end stage renal disease (ESRD). In addition to classical progression factors, other atherosclerosis-related factors, including hyperuricemia (HU), have been associated to the renal progression of IgAN. Increased serum uric...

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

Atypical presentation of Dent disease in a patient with interstitial Xp11.22 deletion

Drovandi S. Servetti M. Angeletti A.

No description

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Long-term blood pressure behavior and progression to end-stage renal disease in patients with immunoglobulin A nephropathy: a single-center observational study in Italy

Russo E. Verzola D. Salvidio G.

BACKGROUND: Antihypertensive treatment by the use of RAAS inhibitors (RAAS-is) is of paramount importance in the management of slowly progressive IgA nephropathy (IgAN). With the aim of better understanding the relationship between BP behavior and progression, we looked at time-averaged SBP and time-averaged proteinuria and renal outcome in a...

Uploaded on: April 14, 2023